The global Non-Small Cell Lung Carcinoma (NSCLC) Market is expected to generate a market value of US$ 8.25 billion in 2023 and a market value of US$ 21.40 billion by 2033, with a CAGR of 10% from 2023 to 2033. The rising prevalence of non-small cell lung carcinoma (NSCLC) worldwide due to increased air pollution and smoking habits among people can be attributed to the growth of the non-small...
English 
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek